Stock Analysis
UnitedHealth Group Incorporated (UNH) Stock Analysis
UnitedHealth Group Incorporated (UNH) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
UnitedHealth Group Incorporated (UNH) currently has an AIQ Score of 49/100, indicating a neutral setup. Risk is the strongest factor at 60/100. Momentum is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
UNH at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $396.30 |
| AIQ Score | 49/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $365.25B |
| P/E Ratio | 25.86 |
| Forward P/E | — |
| EPS | $6.05 |
| Revenue TTM | $112.03B |
| Dividend Yield | 8.95% |
| Beta | 0.63 |
| Volume | 3.72M |
| 52-week range | $255.97-$461.62 |
| RSI 14 | 42.86 |
| 50-Day SMA | $412.40 |
| 200-Day SMA | $350.38 |
| Analyst Price Target | $468.79 |
| Next Earnings | Oct 27, 2026 |
UNH
OverviewUNH Stock Analysis Summary
UnitedHealth Group Incorporated (UNH) currently has an AIQ Score of 49/100/100, indicating a neutral setup. Risk resilience is the strongest factor at 60/100/100. Momentum is the weakest current factor at 43/100/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, UNH has AIQ Score of 49/100 with Risk resilience base of 60/100 and fading Momentum at 43/100. Wait for component alignment before adding exposure.
Healthcare · 1.77% stock move · UNH classified in Medical - Healthcare Plans.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is UNH Bullish or Bearish Right Now?
UNH currently has a neutral overall setup. Risk Resilience is the strongest factor at 60/100, while Momentum is weakest at 43/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Risk Resilience is supportive at 60/100.
- - Analyst target implies +18.29% upside from the latest quote.
- - Momentum is weak at 43/100.
- - Technical consensus has more sell votes than buy votes (23 vs 15).
Current Consensus
UNH's Technical Analysis Consensus is currently Sell, with 15 buy, 7 neutral, and 23 sell votes. UNH's 14-day RSI is 42.86, which places the stock in a weaker momentum range. UNH's beta is 0.63, indicating lower market sensitivity than the broad market.
What Changed in UNH?
Recent score-change history is not available in the current snapshot. The page still shows the latest market-close evidence and timestamps.
What Would Change the UNH Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
UNH Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
UNH Fundamentals
UNH valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
UNH Technical Analysis
UNH technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
UNH Stock Catalysts
Track UNH earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
UNH Dividend Analysis
UNH dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
UNH Financial Data
UNH revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
UNH Risk Analysis
UNH volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
UNH Stock News
UNH stock news, market tone, recent headlines, and catalyst context.
Popular UNH Comparisons
How UNH scores against the names it is most often compared with.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 2, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Value and quality should explain the score, not sit behind it.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for UNH
Scenario Analysis
AIQ Scenario Builder
UnitedHealth Group Incorporated (UNH) Stock Analysis
UnitedHealth Group Incorporated has an AIQ Score of 49/100 in a Neutral regime. Risk is strongest at 60/100.
The main conflict is that risk leads at 60/100 while momentum lags at 43/100. Review the supporting factors together before drawing a conclusion from any single score.
Beta is 0.63, below market sensitivity. Current price is $396.30 and RSI (14) is 42.9.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | UNH is in a Neutral AIQ regime with score 49/100. |
| Signal Conflict | The primary conflict is that risk leads at 60/100 while momentum lags at 43/100. |
| Factor Evidence | Momentum 43/100 · Value 53/100 · Quality 44/100 · Risk 60/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Wait | Risk is the strongest factor at 60/100. |
| Timing | Wait | Momentum is 43/100 and RSI (14) is 42.9. |
| Regime fit | Wait | UNH is in a Neutral regime at 49/100. |
| Risk control | Wait | Risk factor is 60/100 with beta 0.63 and annual volatility 35.58%. |
| Conflict | Pass | Current conflict: risk leads at 60/100 while momentum lags at 43/100. |
| AIQ Score | 49/100/100 |
| Price | $396.30 |
| Beta | 0.63 |
| RSI (14) | 42.9 |
Compare with Similar Stocks
Portfolio Implication
Related Links
Related Links
UNH Stock FAQ
What is UNH stock price today?
UnitedHealth Group Incorporated's current stock price is $396.30. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is UNH bullish or bearish right now?
UNH's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is UNH's market cap?
UNH's market cap is $365.25B based on the latest completed market-close snapshot from Sep 1, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is UNH's current P/E ratio?
UNH's current P/E ratio is 25.86 based on the latest completed market-close snapshot from Sep 1, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is UNH's RSI?
UNH's 14-day RSI is 42.86 based on the latest completed market-close snapshot from Sep 1, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is UNH above its 50-day and 200-day moving averages?
UNH is -3.90% from its 50-day SMA and 13.11% from its 200-day SMA based on the latest completed market-close snapshot from Sep 1, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is UNH's next earnings date?
UNH's next earnings date is currently listed as Oct 27, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does UNH pay a dividend?
UNH's dividend yield is 8.95% based on the latest completed market-close snapshot from Sep 1, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.